Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 274

1.

Obesity and metabolic syndrome: potential benefit from specific nutritional components.

Abete I, Goyenechea E, Zulet MA, Martínez JA.

Nutr Metab Cardiovasc Dis. 2011 Sep;21 Suppl 2:B1-15. doi: 10.1016/j.numecd.2011.05.001. Epub 2011 Jul 20. Review.

PMID:
21764273
2.

Role of ω3 long-chain polyunsaturated fatty acids in reducing cardio-metabolic risk factors.

Abeywardena MY, Patten GS.

Endocr Metab Immune Disord Drug Targets. 2011 Sep 1;11(3):232-46. Review.

PMID:
21831036
3.

Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA- cp rat model of the metabolic syndrome.

Lu J, Borthwick F, Hassanali Z, Wang Y, Mangat R, Ruth M, Shi D, Jaeschke A, Russell JC, Field CJ, Proctor SD, Vine DF.

Br J Nutr. 2011 Jun;105(11):1572-82. doi: 10.1017/S0007114510005453. Epub 2011 Jan 31.

PMID:
21276281
4.

Insulin resistance determines a differential response to changes in dietary fat modification on metabolic syndrome risk factors: the LIPGENE study.

Yubero-Serrano EM, Delgado-Lista J, Tierney AC, Perez-Martinez P, Garcia-Rios A, Alcala-Diaz JF, Castaño JP, Tinahones FJ, Drevon CA, Defoort C, Blaak EE, Dembinska-Kieć A, Risérus U, Lovegrove JA, Perez-Jimenez F, Roche HM, Lopez-Miranda J.

Am J Clin Nutr. 2015 Dec;102(6):1509-17. doi: 10.3945/ajcn.115.111286. Epub 2015 Nov 11.

PMID:
26561628
5.

n-3 long-chain polyunsaturated fatty acids in type 2 diabetes: a review.

Nettleton JA, Katz R.

J Am Diet Assoc. 2005 Mar;105(3):428-40. Review.

PMID:
15746832
6.

Dietary treatment of the metabolic syndrome--the optimal diet.

Riccardi G, Rivellese AA.

Br J Nutr. 2000 Mar;83 Suppl 1:S143-8. Review.

PMID:
10889805
7.
8.

Metabolic syndrome: definition and therapeutic implications.

Prasad H, Ryan DA, Celzo MF, Stapleton D.

Postgrad Med. 2012 Jan;124(1):21-30. doi: 10.3810/pgm.2012.01.2514. Review.

PMID:
22314111
10.

Pharmacotherapy of mixed dyslipidemia in the metabolic syndrome.

Nakajima K.

Curr Clin Pharmacol. 2010 May;5(2):133-9. Review.

PMID:
20156152
11.

Mediterranean diet and metabolic syndrome: the evidence.

Babio N, Bulló M, Salas-Salvadó J.

Public Health Nutr. 2009 Sep;12(9A):1607-17. doi: 10.1017/S1368980009990449. Review.

PMID:
19689829
12.

The metabolic syndrome and its cardiovascular manifestations.

Sánchez-Torres RJ, Delgado-Osorio H.

Bol Asoc Med P R. 2005 Oct-Dec;97(4):271-80. Review.

PMID:
16599068
13.

The metabolic syndrome: definitions, prevalence and management.

Levesque J, Lamarche B.

J Nutrigenet Nutrigenomics. 2008;1(3):100-8. doi: 10.1159/000112457. Epub 2008 Feb 20. Review.

PMID:
19776619
14.

Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study.

Xu A, Tso AW, Cheung BM, Wang Y, Wat NM, Fong CH, Yeung DC, Janus ED, Sham PC, Lam KS.

Circulation. 2007 Mar 27;115(12):1537-43.

15.

Impact of non-alcoholic fatty liver disease on accelerated metabolic complications.

Fan JG.

J Dig Dis. 2008 May;9(2):63-7. doi: 10.1111/j.1751-2980.2008.00323.x. Review.

PMID:
18419637
16.

Metabolic syndrome and non-alcoholic fatty liver disease: Asian definitions and Asian studies.

Fan JG, Peng YD.

Hepatobiliary Pancreat Dis Int. 2007 Dec;6(6):572-8. Review.

17.

Relations between metabolic syndrome, oxidative stress and inflammation and cardiovascular disease.

Holvoet P.

Verh K Acad Geneeskd Belg. 2008;70(3):193-219. Review.

PMID:
18669160
18.

What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?

Fan JG, Saibara T, Chitturi S, Kim BI, Sung JJ, Chutaputti A; Asia-Pacific Working Party for NAFLD.

J Gastroenterol Hepatol. 2007 Jun;22(6):794-800. Epub 2007 May 13.

PMID:
17498218
19.

N-3 long chain polyunsaturated fatty acids: a nutritional tool to prevent insulin resistance associated to type 2 diabetes and obesity?

Delarue J, LeFoll C, Corporeau C, Lucas D.

Reprod Nutr Dev. 2004 May-Jun;44(3):289-99. Review.

PMID:
15460168
20.

Role of diet and nutritional management in non-alcoholic fatty liver disease.

Fan JG, Cao HX.

J Gastroenterol Hepatol. 2013 Dec;28 Suppl 4:81-7. doi: 10.1111/jgh.12244.

PMID:
24251710

Supplemental Content

Support Center